Roche Diagnostics Corp.: FDA filings under this applicant name

FDA lists 451 510(k) clearances under 4 spellings of the applicant name “Roche Diagnostics Corp.” (first 1999, latest 2026), plus 15 PMA and 3 De Novo decisions, across 151 product codes in 7 review panels. Median 510(k) review time under this name: 75 days. Since 2017 the median was 166 days, against 200 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

Caduvo groups this applicant name under Roche Diagnostics, based on public ownership records.

510(k) clearances per year

YearClearancesMedian review days
201212138
20131064
20141689
2015585
20166164
201710123
20187132
2019489
20203160
20214224
202210217
20237228
20243266
2025690
2026990

Review time against the same product codes

Since 2017, 510(k)s cleared under the name Roche Diagnostics Corp. took a median 166 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 200 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
JJXSingle (Specified) Analyte Controls (Assayed And Unassayed)5858
JJYMulti-Analyte Controls, All Kinds (Assayed)2222
NBWSystem, Test, Blood Glucose, Over The Counter1919
JITCalibrator, Secondary1818
GJSTest, Time, Prothrombin1414
JIXCalibrator, Multi-Analyte Mixture1414
LFRGlucose Dehydrogenase, Glucose1212
DKZEnzyme Immunoassay, Amphetamine1010
SEIQualitative And Quantitative Hepatitis B Virus Antibody Assays102
CGNAcid, Folic, Radioimmunoassay77

Plus 141 more product codes.

Review panels

Most recent Roche Diagnostics Corp. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K261686Elecsys Phospho-Tau (217P) PlasmaSET2026-08-1990
K252323cobas pulse blood glucose monitoring systemPZI2026-06-12322
K252280Elecsys Anti-SARS-CoV-2 SQVP2026-04-13265
K260049Elecsys Anti-HBc IgMSEI2026-04-0790
K260048Elecsys Anti-HAV IgMLOL2026-04-0790
K260046Elecsys Anti-HBc IISEI2026-04-0790
K260026Tina-quant Cardiac high sensitivity CRP IIINQD2026-04-0287
K253491ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutionsCEM2026-02-12111
K253490Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsCFR2026-02-12111
K253839Elecsys Anti-SARS-CoV-2QVP2025-12-1716

441 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
P190034PMAElecsys Anti-HBs II, PreciControl Anti-HBs, Anti-HBs CalCheck2021-02-23
P190005PMAElecsys Anti-HBe, PreciControl Anti-HBe2021-02-03
P160019PMAElecsys HBsAg II/Elecsys HBsAg Confirmatory Test/ PreciControl HBsAg II2016-12-23
DEN150057De NovoAnti-Müllerian Hormone Test System2016-12-19
DEN130002De NovoHemoglobin A1c Test System2013-05-23

Recalls

240 product recalls in 107 recall events; 0 initiated in the last five years. Most recent: 2019-06-03.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Related HCPCS codes

HCPCS Level II codes whose descriptors match the device names of the product codes filed under Roche Diagnostics Corp. (a text match, not an official crosswalk):

FDA spellings included

FDA records this applicant under 4 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under Roche Diagnostics Corp.?

FDA lists 451 510(k) clearances under 4 spellings of the applicant name “Roche Diagnostics Corp.” (first 1999, latest 2026), plus 15 PMA and 3 De Novo decisions, across 151 product codes in 7 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Roche Diagnostics Corp.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Roche Diagnostics Corp. is 75 days. Since 2017: 166 days, versus 200 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under Roche Diagnostics Corp.?

The most frequent FDA product codes under this applicant name are JJX (Single (Specified) Analyte Controls (Assayed And Unassayed), 58); JJY (Multi-Analyte Controls, All Kinds (Assayed), 22); NBW (System, Test, Blood Glucose, Over The Counter, 19).

Next steps

Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name (spelling variants such as punctuation and legal suffixes combined); filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.

All FDA device companies · FDA product code lookup